abstract |
The present invention relates to pyridopyrimidine derivatives according to formula (I) as autotaxin inhibitors and physiological and / or amplified and mediated and / or amplified by elevated lysophosphatidic acid levels and / or activation of autotaxin. Or the use of such compounds for the treatment and / or prevention of pathophysiological conditions, in particular different cancers. |